QuantumScape (QS) Faces A Fresh Test Following Its Q2 Pivot And $85 Fair Value Narrative

QuantumScape

QuantumScape

QS

0.00

Why QuantumScape’s Q2 Pivot Matters For Investors

QuantumScape (QS) has unsettled some investors with its Q2 update. The company is shifting from building battery factories to licensing its solid state technology, while pushing its commercial readiness timeline out to 2029.

This change in direction, combined with the continued absence of revenue, has become a key focus for anyone tracking QuantumScape stock and reassessing the risk profile around its long term electric vehicle battery plans.

QuantumScape’s Q2 update has landed after a tough stretch for the stock, with the share price down 45.03% year to date and the 1 year total shareholder return declining 30.59%. The recent Q2 pivot and extended 2029 timeline have been met with selling pressure, including a sharp fall in July. However, the 1 day share price return of 9.95% and 7 day share price return of 16.48% suggest a short term bounce as investors reassess the risk and potential of the licensing model.

If you are weighing QuantumScape’s reset against other opportunities in the energy and infrastructure story around electrification, this is a good time to scan 36 power grid technology and infrastructure stocks

QuantumScape now trades on a much smaller market value, yet still faces a long wait to 2029 and continuing losses. Does that reset tilt the balance between risk and reward in favor of new buyers, or does it argue for more caution from here?

Most Popular Narrative: 92.8% Undervalued

At a last close of $6.08, the most followed narrative on QuantumScape sets a fair value of $85. This gap frames the stock as a high risk, high potential story built around its solid state battery platform and licensing pivot.

QuantumScape is the only battery company to demonstrate OEM‑validated solid‑state lithium‑metal performance at automotive‑relevant conditions. The market still prices QS as a speculative science project. That window is closing.

This narrative leans heavily on OEM validation, ceramic separator performance, and long term end markets. The fair value is based on ambitious revenue scaling and margin assumptions that only make sense if those technical milestones and licensing economics align over time.

Result: Fair Value of $85 (UNDERVALUED)

However, this QuantumScape narrative still hinges on unproven large scale manufacturing, as well as on customers adopting a licensing model that is not yet validated in the market.

Another View On QuantumScape’s Valuation

The popular QuantumScape narrative leans on a fair value of $85, yet the stock sits at $6.08 with no meaningful revenue and ongoing losses of $404.97m. On a P/B of 3.6x versus 1.6x for the US Auto Components industry and 1.9x for peers, the stock appears expensive rather than cheap. This raises the question of whether that gap reflects genuine technology potential or simply increases the amount that needs to go right from here.

NasdaqGS:QS P/B Ratio as at Aug 2026
NasdaqGS:QS P/B Ratio as at Aug 2026

Next Steps

If this QuantumScape story feels finely balanced between concern and optimism, then it makes sense to check the details yourself and act quickly. A useful place to start is by weighing the 2 key rewards and 3 important warning signs.

Looking For More Investment Ideas Beyond QuantumScape?

QuantumScape may be on your radar, but you do not want to miss other opportunities that could fit your goals even better. Use the Simply Wall Street Screener to quickly surface ideas that match your risk comfort, income needs, and growth focus, then compare them against QuantumScape while this update is still fresh in your mind.

  • Target potential value opportunities before others notice by scanning 51 high quality undervalued stocks that currently look cheap relative to their fundamentals.
  • Secure more dependable income streams by reviewing 8 dividend fortresses that focus on higher yields.
  • Prioritize capital protection by checking 79 resilient stocks with low risk scores that screen for steadier risk profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.